SEC Form 4 · accession 0000904454-18-000405
uniQure N.V. · QURE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Zelenkofske
Officer — Chief Medical Officer
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 8:58 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001590560
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Jun 6, 2018 | S | 23,929 | $37.14 | D | 159,458 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.
- F2The price reported in Column 4 is a weighted average price. 23,829 of such shares were sold in multiple transactions at prices ranging from $36.70 to $37.69, and 100 of such shares were sold at $37.73. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.